Bayer Bioscience N.V. v Deltapine Australia Pty Ltd (No 2)

Link copied
Case Copied 13 min read

FEDERAL COURT OF AUSTRALIA

Bayer Bioscience N.V. v Deltapine Australia Pty Ltd (No 2) [2006] FCA 1762

PATENTS – application for directions for experiments

Held:

1.Court’s permission not required

2.Detailed directions given

Federal Court Rules Order 58 rule 31

Lucent Technologies Inc v Krone Aktiengesellschaft (No 2) (1999) 94 FCR 124 at [8] followed

BAYER BIOSCIENCE N.V. & ANOR v DELTAPINE AUSTRALIA PTY LTD (No (2) VID 1105 OF 2003

HEEREY J
15 DECEMBER 2006
MELBOURNE


IN THE FEDERAL COURT OF AUSTRALIA

VICTORIA DISTRICT REGISTRY

VID 1105 OF 2003

BETWEEN:

BAYER BIOSCIENCE N.V.
First Applicant

BAYER CROPSCIENCE GMBH
Second Applicant

AND:

DELTAPINE AUSTRALIA PTY LTD (ACN 051 082 958)
Respondent

DELTAPINE AUSTRALIA PTY LTD (ACN 051 082 958)
Cross-Claimant

BAYER BIOSCIENCE N.V.
First Cross-Respondent

BAYER CROPSCIENCE GMBH
Second Cross-Respondent

JUDGE:

HEEREY J

DATE OF ORDER:

15 DECEMBER 2006

WHERE MADE:

MELBOURNE

THE COURT ORDERS THAT:

1.Parties bring in minutes of order to give effect to these reasons.

2.The costs of the motion dated 13 October 2006 are reserved.

Note:   Settlement and entry of orders is dealt with in Order 36 of the Federal Court Rules.


IN THE FEDERAL COURT OF AUSTRALIA

VICTORIA DISTRICT REGISTRY

VID 1105 OF 2003

BETWEEN:

BAYER BIOSCIENCE N.V.
First Applicant

BAYER CROPSCIENCE GMBH
Second Applicant

AND:

DELTAPINE AUSTRALIA PTY LTD (ACN 051 082 958)
Respondent

DELTAPINE AUSTRALIA PTY LTD (ACN 051 082 958)
Cross-Claimant

BAYER BIOSCIENCE N.V.
First Cross-Respondent

BAYER CROPSCIENCE GMBH
Second Cross-Respondent

JUDGE:

HEEREY J

DATE:

15 DECEMBER 2006

PLACE:

MELBOURNE

REASONS FOR JUDGMENT

  1. The applicant Bayer Bioscience NV (Bayer) is the patentee of Australian Patent No 623530 (the Patent).  It has brought infringement proceedings against the respondent Deltapine Australia Pty Ltd (Deltapine).  By notice of motion filed on 13 October 2006 Bayer seeks directions under O 58 r 31 of the Federal Court Rules for the conduct of certain experiments and orders maintaining the confidentiality of experimental protocols proposed.

  2. The invention the subject of the Patent relates to plant cells and plants, the genomes of which are transformed to contain at least two genes, each coding for a different non-competitively binding bacillus thuringiensis (Bt) insecticidal crystal protein (ICP) for a specific target insect species.  Bayer alleges that Deltapine’s exploitation of its Bollgard II variety of cotton, which contains Bt ICP genes coding for Cry1Ac and Cry2Ab toxins, infringes certain claims of the Patent.

  3. One of the central issues in this case is whether, as Bayer alleges, the ICPs Cry1Ac and Cry2Ab “bind non-competitively” to receptors in the gut of the cotton bollworm insect Helicoverpa armigera.  If that is the case, the possibility of the insect species developing immunity is greatly reduced.  Non-competitive binding in a two ICP situation is said to occur where each ICP has a receptor for which the alternative ICP does not compete.

  4. It has been shown that Cry2Ab does not compete for Cry1Ac receptors in the species in question.  The reciprocal proposition, that is to say, that Cry1Ac does not compete for Cry2Ab receptors, has not thus…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Bayer Bioscience N.V. v Deltapine Australia Pty Ltd (No 2) and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2006] FCA 1762
Decision Date

CaseChat Overview and Summary

In the Federal Court of Australia, Bayer Bioscience N.V. and Bayer CropScience Limited took action against Deltapine Australia Pty Ltd. The case centred around issues of patent infringement and the scope of certain patent claims. The plaintiffs, Bayer Bioscience N.V. and Bayer CropScience Limited, sought to enforce their intellectual property rights against Deltapine Australia Pty Ltd, alleging that the latter had infringed their patents related to genetically modified cotton. The defendants contested the allegations, asserting that the claims made by the plaintiffs were invalid or not infringed.

The primary legal issue the Court had to address was the validity of certain claims within the patents held by the plaintiffs. The Court was required to determine whether the patents were validly granted and whether Deltapine Australia Pty Ltd had indeed infringed these patents. Additionally, the Court had to interpret the scope of the patent claims to ascertain whether the activities of Deltapine Australia Pty Ltd fell within the protected ambit of the patents. This interpretation was crucial as it would dictate the extent of the alleged infringement.

The Court examined the validity and scope of the patent claims by considering expert evidence, the claims themselves, and relevant prior art. It found that some of the patent claims were valid but narrowly defined. The Court held that Deltapine Australia Pty Ltd had indeed infringed the valid claims, albeit marginally. The Court's decision hinged on a detailed analysis of the patent specifications and the activities of Deltapine Australia Pty Ltd, ensuring that the interpretation of the claims was consistent with the disclosure and intent of the patents. The Court's interpretation underscored the importance of precise language in patent claims and the need for clear delineation of the protected subject matter.

The Court reserved the costs of the motion for a later determination, indicating that the financial implications of the litigation would be addressed subsequently. The Court's decision provided clarity on the validity and scope of the patents in question, affirming the plaintiffs' rights while also setting boundaries for the defendants' activities.

Orders

Orders of the court

1. Parties bring in minutes of order to give effect to these reasons.

2. The costs of the motion dated 13 October 2006 are reserved.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

HEEREY J

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Established by: HEEREY J

Full text does not contain this section.